CHORUS AVIATION INC (CHR.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:CHR - CA17040T8885 - Common Stock
21.56 CAD
-0.04 (-0.19%)
We assign a fundamental rating of 4 out of 10 to CHR. CHR was compared to 6 industry peers in the Passenger Airlines industry. Both the profitability and the financial health of CHR get a neutral evaluation. Nothing too spectacular is happening here. CHR has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CHR was profitable.
CHR had a positive operating cash flow in the past year.
In multiple years CHR reported negative net income over the last 5 years.
CHR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CHR has a worse Return On Assets (-2.62%) than 60.00% of its industry peers.
CHR's Return On Equity of -6.31% is fine compared to the rest of the industry. CHR outperforms 80.00% of its industry peers.
CHR has a Return On Invested Capital of 6.40%. This is amongst the best in the industry. CHR outperforms 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CHR is in line with the industry average of 4.35%.
The last Return On Invested Capital (6.40%) for CHR is above the 3 year average (5.30%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.62% | ||
| ROE | -6.31% | ||
| ROIC | 6.4% |
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
1.3 Margins
The Operating Margin of CHR (6.81%) is better than 80.00% of its industry peers.
CHR's Operating Margin has declined in the last couple of years.
CHR has a Gross Margin of 65.68%. This is amongst the best in the industry. CHR outperforms 100.00% of its industry peers.
CHR's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.81% | ||
| PM (TTM) | N/A | ||
| GM | 65.68% |
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHR is destroying value.
Compared to 1 year ago, CHR has less shares outstanding
Compared to 5 years ago, CHR has more shares outstanding
CHR has a better debt/assets ratio than last year.
2.2 Solvency
CHR has an Altman-Z score of 0.90. This is a bad value and indicates that CHR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.90, CHR is in line with its industry, outperforming 60.00% of the companies in the same industry.
The Debt to FCF ratio of CHR is 10.63, which is on the high side as it means it would take CHR, 10.63 years of fcf income to pay off all of its debts.
CHR's Debt to FCF ratio of 10.63 is amongst the best of the industry. CHR outperforms 100.00% of its industry peers.
A Debt/Equity ratio of 0.50 indicates that CHR is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.50, CHR is doing good in the industry, outperforming 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 10.63 | ||
| Altman-Z | 0.9 |
ROIC/WACC0.79
WACC8.11%
2.3 Liquidity
CHR has a Current Ratio of 1.22. This is a normal value and indicates that CHR is financially healthy and should not expect problems in meeting its short term obligations.
CHR has a Current ratio (1.22) which is in line with its industry peers.
CHR has a Quick Ratio of 1.22. This is a bad value and indicates that CHR is not financially healthy enough and could expect problems in meeting its short term obligations.
CHR has a worse Quick ratio (0.63) than 60.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.63 |
3. Growth
3.1 Past
CHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 92.86%, which is quite impressive.
The earnings per share for CHR have been decreasing by -19.03% on average. This is quite bad
The Revenue has decreased by -8.40% in the past year.
The Revenue has been growing slightly by 0.56% on average over the past years.
EPS 1Y (TTM)92.86%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%42.86%
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-5.39%
3.2 Future
Based on estimates for the next years, CHR will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.19% on average per year.
The Revenue is expected to decrease by -4.52% on average over the next years.
EPS Next Y61.87%
EPS Next 2Y14.11%
EPS Next 3Y14.19%
EPS Next 5YN/A
Revenue Next Year-6.45%
Revenue Next 2Y-5.27%
Revenue Next 3Y-4.52%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
CHR is valuated reasonably with a Price/Earnings ratio of 8.87.
100.00% of the companies in the same industry are more expensive than CHR, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.19. CHR is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 10.97, the valuation of CHR can be described as very reasonable.
Based on the Price/Forward Earnings ratio, CHR is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of CHR to the average of the S&P500 Index (23.92), we can say CHR is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.87 | ||
| Fwd PE | 10.97 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHR indicates a somewhat cheap valuation: CHR is cheaper than 80.00% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CHR is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.54 | ||
| EV/EBITDA | 3.91 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CHR's earnings are expected to grow with 14.19% in the coming years.
PEG (NY)0.14
PEG (5Y)N/A
EPS Next 2Y14.11%
EPS Next 3Y14.19%
5. Dividend
5.1 Amount
CHR has a Yearly Dividend Yield of 1.48%.
CHR's Dividend Yield is a higher than the industry average which is at 1.02.
CHR's Dividend Yield is slightly below the S&P500 average, which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.48% |
5.2 History
On average, the dividend of CHR grows each year by 21.58%, which is quite nice.
CHR has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)21.58%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CHR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of CHR is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-5.89%
EPS Next 2Y14.11%
EPS Next 3Y14.19%
TSX:CHR (1/9/2026, 7:00:00 PM)
21.56
-0.04 (-0.19%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)
Earnings (Next)
Inst Owners3.74%
Inst Owner ChangeN/A
Ins Owners1.28%
Ins Owner ChangeN/A
Market Cap504.94M
Revenue(TTM)1.35B
Net Income(TTM)-34.96M
Analysts78.18
Price Target30.26 (40.35%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.48% |
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-5.89%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.44%
Min EPS beat(2)3.86%
Max EPS beat(2)11.03%
EPS beat(4)4
Avg EPS beat(4)11.06%
Min EPS beat(4)3.86%
Max EPS beat(4)25.51%
EPS beat(8)6
Avg EPS beat(8)17.12%
EPS beat(12)6
Avg EPS beat(12)4.64%
EPS beat(16)8
Avg EPS beat(16)3.17%
Revenue beat(2)0
Avg Revenue beat(2)-6.2%
Min Revenue beat(2)-8.31%
Max Revenue beat(2)-4.09%
Revenue beat(4)0
Avg Revenue beat(4)-5.03%
Min Revenue beat(4)-8.31%
Max Revenue beat(4)-3.78%
Revenue beat(8)2
Avg Revenue beat(8)-4.05%
Revenue beat(12)5
Avg Revenue beat(12)-1.79%
Revenue beat(16)7
Avg Revenue beat(16)0.32%
PT rev (1m)0%
PT rev (3m)5.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.14%
EPS NY rev (1m)0%
EPS NY rev (3m)4.22%
Revenue NQ rev (1m)-2.01%
Revenue NQ rev (3m)-2.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.68%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.87 | ||
| Fwd PE | 10.97 | ||
| P/S | 0.37 | ||
| P/FCF | 15.54 | ||
| P/OCF | 7.09 | ||
| P/B | 0.91 | ||
| P/tB | 0.93 | ||
| EV/EBITDA | 3.91 |
EPS(TTM)2.43
EY11.27%
EPS(NY)1.97
Fwd EY9.12%
FCF(TTM)1.39
FCFY6.44%
OCF(TTM)3.04
OCFY14.1%
SpS57.62
BVpS23.67
TBVpS23.29
PEG (NY)0.14
PEG (5Y)N/A
Graham Number35.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.62% | ||
| ROE | -6.31% | ||
| ROCE | 8.63% | ||
| ROIC | 6.4% | ||
| ROICexc | 6.56% | ||
| ROICexgc | 6.62% | ||
| OM | 6.81% | ||
| PM (TTM) | N/A | ||
| GM | 65.68% | ||
| FCFM | 2.41% |
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexgc growth 3Y33.52%
ROICexgc growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score6
Asset Turnover1.01
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 10.63 | ||
| Debt/EBITDA | 1.32 | ||
| Cap/Depr | 32.58% | ||
| Cap/Sales | 2.87% | ||
| Interest Coverage | 2.74 | ||
| Cash Conversion | 33.79% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.63 | ||
| Altman-Z | 0.9 |
F-Score6
WACC8.11%
ROIC/WACC0.79
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.86%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%42.86%
EPS Next Y61.87%
EPS Next 2Y14.11%
EPS Next 3Y14.19%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-5.39%
Revenue Next Year-6.45%
Revenue Next 2Y-5.27%
Revenue Next 3Y-4.52%
Revenue Next 5YN/A
EBIT growth 1Y-34.45%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year87.77%
EBIT Next 3Y14.37%
EBIT Next 5YN/A
FCF growth 1Y-89.3%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-80.17%
OCF growth 3Y12.73%
OCF growth 5Y0.25%
CHORUS AVIATION INC / CHR.CA FAQ
What is the fundamental rating for CHR stock?
ChartMill assigns a fundamental rating of 4 / 10 to CHR.CA.
Can you provide the valuation status for CHORUS AVIATION INC?
ChartMill assigns a valuation rating of 6 / 10 to CHORUS AVIATION INC (CHR.CA). This can be considered as Fairly Valued.
Can you provide the profitability details for CHORUS AVIATION INC?
CHORUS AVIATION INC (CHR.CA) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for CHR stock?
The Price/Earnings (PE) ratio for CHORUS AVIATION INC (CHR.CA) is 8.87 and the Price/Book (PB) ratio is 0.91.
How financially healthy is CHORUS AVIATION INC?
The financial health rating of CHORUS AVIATION INC (CHR.CA) is 4 / 10.